Quantum X Labs Inc Dossier
Qualitative Analysis
Business overview
Quantum X Labs Inc. (NASDAQ: QXL), formerly known as Viewbix Inc. until its rebranding in April 2026, is an advanced technology company transitioning toward the research, development, and commercialization of full-spectrum quantum technologies. The company operates through a dual-track model: it maintains its legacy digital advertising and AI-driven computing businesses (via Gix Media Ltd. and Metagramm Software Ltd.) to generate diversified revenue, while rapidly expanding its core quantum portfolio. This quantum ecosystem is anchored by its wholly-owned subsidiary, Quantum X Labs Ltd., and is organized into specialized portfolio operations including Quantum Gyro, Quantum Atom Accuracy, CliniQuantum, QuantumQ Security, Quantum Transportation, and Nuclear Quantum. Its technological pillars focus on cold/natural atom quantum computing, quantum error correction software (including a pending patent for AI-Quantum Error Correction), quantum simulation, and quantum sensing technologies such as gyroscopes and atomic clocks.
Research as of 24 Jul 2026
Strategic Initiatives
Growth programs, investments, and their expected impact
Comprehensive corporate rebranding from Viewbix Inc. (VBIX) to Quantum X Labs Inc. (QXL) to formalize the company's strategic shift toward researching, developing, and commercializing quantum computing, quantum error correction, quantum simulation, and quantum sensing technologies.
Expected impact: Positions the company as a leading public player in the emerging quantum technology sector, transitioning from its legacy digital advertising roots.
Launching an integrated program that combines CliniQuantum's quantum algorithms for clinical trial data analysis with Quantum X Labs' proprietary Quantum Error Correction Decoder technology.
Expected impact: Aims to enhance computational accuracy and accelerate biomedical data analysis for drug discovery and clinical trials by testing across multiple quantum processor platforms.
Mergers, Acquisitions & Partnerships
Recent deals and strategic collaborations
Recent Acquisitions
Acquisition of 100% of the fully diluted share capital of Quantum X Labs Ltd., a multidisciplinary Israeli quantum technology hub. This acquisition serves as the foundation for the company's strategic pivot, securing a specialized intellectual property portfolio (including a pending patent for AI-Quantum Error Correction) and an ecosystem of portfolio companies focused on quantum navigation, precision timing, and quantum algorithms.
Financial impact: The transaction involved issuing common stock and pre-funded warrants representing approximately 40% of Viewbix's capital stock, with up to 12.7 million additional shares subject to post-closing milestones. It was accompanied by a concurrent private placement raising $1.4 million in gross proceeds.
Strategic Partnerships
Enables Quantum X Labs to evaluate its AI-based quantum error-correction technology (specifically its patented Deep Transformer Decoder) on Quantum Machines' real-time quantum control infrastructure (OPX1000) under realistic operating conditions.
Terms: Terms not publicly disclosed; IQCC provides access to its quantum control and orchestration infrastructure.